Trending Topics in Health-System Pharmacy

William (Bill) Zellmer, BSPharm, MPH, ScD (Hon), is a visionary in the pharmacy profession. He draws on many years of experience in leadership positions in pharmacy, both in the United States and abroad.

Aiya Almogaber, PharmD

Many health systems have been caught off-guard by a sharp plunge in drug availability due to the unforeseen demand of certain medications created by the COVID-19 pandemic.

Corey Diamond, PharmD

Adults treated with empagliflozin (Jardiance—Boehringer Ingelheim, Lilly) during hospitalization for an acute heart failure (HF) event had reduced all-cause mortality, fewer HF events, and improvement in HF–related symptoms compared with those given a placebo, according to results of the EMPULSE trial presented at the 2021 American Heart Association (AHA) Scientific Sessions.

Maria G. Tanzi, PharmD

We know that dexamethasone reduces morbidity and mortality associated with COVID-19 infections. Does a higher daily intake of dexamethasone reduce morbidity and mortality further?

Joey Sweeney, PharmD, BCPS